Customer, organizational and financial trends are disrupting the Biotechnology sector, and thereby shaping new and growing Biotech companies. These trends require companies and their finance functions to reinvent themselves.
Finance is critical to both the Research and Development (R&D) and Commercialization stages of these companies. While Finance cannot deliver on the goals of each of these stages by itself, it can empower other functions through collaboration, answering their needs with regards to budgeting and reporting, talent development and process and technology integration.
In this guide, we explore:
- The key developments in the Life Sciences sector that require Biotech organizations to become more innovative and agile across the organization, beyond R&D, in order to future-proof their business – and which trends are impacting the finance function;
- Trends in Finance;
- How Finance can be an enabler in the R&D and Commercialization stages; and
- What a mature Biotech’s Finance organization might look like.
Contact our CFO Advisory and Life Sciences experts
Connect with us
- Find office locations kpmg.findOfficeLocations
- kpmg.emailUs
- Social media @ KPMG kpmg.socialMedia
